Medipak Limited
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Pharmaceutical and medical-device manufacturer · Lahore · Pakistan
Lahore-based manufacturer established in 1982, producing infusion solutions, IV sets, medical devices, ophthalmic products, solid dosage forms and injectables.
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical and medical-device manufacturer
- Address
- 132/1, Quaid-e-Azam Industrial Estate, Kot Lakhpat, Lahore 54700, Pakistan · 54700
- Website
- medipakpharma.com ↗
- Phone
- +92 42 111 017 017
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Medigyl | Metronidazole | 0.5 % | Injection | 100ml | 010005 | PKR 189.93 | PKR 1.90/mL | Near median |
| Medigyl | Metronidazole | 0.5 % | Injection | 100ml | 085218 | PKR 189.93 | PKR 1.90/mL | Near median |
| Medigyl | Metronidazole | 400 mg | Tablet | 20x10's | 085824 | PKR 582.44 | PKR 2.91/tablet | Near median |
| Medigyl | Metronidazole | 0.5 g | Injection | 100ml | 087869 | PKR 189.93 | PKR 1.90/mL | No comparator |
| Medilact – D forSource observed | Ringer's lactate solution + Dextrose | NaCl 0.60g + KCl 0.03g + CaCl2 0.02g + Na lactate 50% + Dextrose 5.0g/100 mL | Injection | 500ml | 093965Official source ↗ | No indexed price | — | — |
| Medilact – D forSource observed | Ringer's lactate electrolytes + Dextrose | 0.60 g | IV infusion | 1000ml | 093966Official source ↗ | No indexed price | — | — |
| Medilact – D solution for Injection Each 100ml contains:Sodium Chloride…………0.60gmPotassium Chloride………..0.03gmCalcium Chloride 2H2O...0.02gmSodium Lactate 50% Sol…..0.62gmDextrose Monohydrate…….5.0gmWater for injection q.s……..100mlSource observed | — | — | — | 1000ml | 093966Official source ↗ | No indexed price | — | — |
| Medilact-D | Water for Injection | 0.03 g + 0.02 g + 0.60 g + 0.31 g + 5 g / 100 mL | IV infusion | 1000ml | 014262 | PKR 222.67 | PKR 0.22/mL | No comparator |
| Medilatan Eye | Latanoprost | 0.05 mg/mL | Ophthalmic drops | 2.5ml | 107268 | PKR 717.33 | PKR 286.93/mL | 24% above median |
| Medimalt Chewable | Elemental Iron | 100 mg | Tablet | 20's | 098084 | PKR 272.97 | PKR 13.65/tablet | Near median |
| Medimalt plus chew | Iron polymaltose complex + Folic acid | 100 mg + 0.35 mg | Tablet | 30's | 100605 | PKR 378.95 | PKR 12.63/tablet | Near median |
| Mediosta | Oseltamivir | 75 mg | Capsule | 10's | 107264 | PKR 990.19 | PKR 99.02/capsule | 18% below median |
| Medipak-C | Ascorbic acid | 500 mg | Chewable tablet | 40's | 107265 | PKR 39.61 | PKR 0.99/tablet | 25% below median |
| Mediquin | Mefloquine | 250 mg | Tablet | 10's | 040736 | PKR 446.55 | PKR 44.66/tablet | Near median |
| Medisol | Dextrose + Sodium chloride | NaCl 0.18g + Dextrose 4.3g/100 mL | IV infusion | 500ml | 009695 | PKR 119.36 | PKR 0.24/mL | Near median |
| Medisol | Sodium chloride + Potassium chloride + Sodium lactate | NaCl 4.0g + KCl 2.6g + Na lactate 50%/1000 mL | Injection | 500ml | 010421 | PKR 39.64 | PKR 0.08/mL | No comparator |
| Medisol | Mannitol | 20 % | IV infusion | 500ml | 022538 | PKR 264.99 | PKR 0.53/mL | Near median |
| Medisol | Dextrose | 5% | IV infusion | 1000ml | 083355 | PKR 189.54 | PKR 0.19/mL | 12% above median |
| Medisol | Dextrose | 5% | IV infusion | 1000ml | 084877 | PKR 189.54 | PKR 0.19/mL | 12% above median |
| Medisol | Anticoagulant citrate dextrose solution | Na citrate 2.20g + Citric acid 0.73g + Dextrose 2.20g/100 mL | Injection | 500ml | 086437 | PKR 495.52 | PKR 0.99/mL | No comparator |
| Medisol | Dextrose Anhydrous | 5 % | IV infusion | 100ml | 093768 | PKR 112.25 | PKR 1.12/mL | 251% above median |
| Medisol | Dextrose + Sodium chloride | NaCl 0.45g + Dextrose 5g/100 mL | IV infusion | 500ml | 094647 | PKR 139.84 | PKR 0.28/mL | 22% above median |
| Medisol 1/2 NS | Sodium chloride | 0.45 g | IV infusion | 1000ml | 083359 | PKR 106.79 | PKR 0.11/mL | 59% below median |
| Medisol 1/2 NS | Sodium chloride | 0.45 g | IV infusion | 1000ml | 084881 | PKR 106.79 | PKR 0.11/mL | 59% below median |
| Medisol 1/2 NS | Sodium chloride | 0.45 g | Injection | 100ml | 106347 | PKR 88.54 | PKR 0.89/mL | No comparator |
| Medisol 1/2 NS | Sodium chloride | 0.45% w/v | IV infusion | 250ml | 106348 | PKR 103.55 | PKR 0.41/mL | No comparator |
| Medisol 1/2 NS | Sodium chloride | 0.45% w/v | Injection | 500ml | 106349 | PKR 120.05 | PKR 0.24/mL | Near median |
| Medisol 1/2 NS | Sodium chloride | 0.45 g | IV infusion | 100ml | 106350 | PKR 88.54 | PKR 0.89/mL | 718% above median |
| Medisol 1/2 NS | Sodium chloride | 0.45% w/v | Injection | 500ml | 106358 | PKR 120.05 | PKR 0.24/mL | Near median |
| Medisol 1/2 NS IV | Sodium chloride | 0.45 g | IV infusion | 250ml | 106351 | PKR 103.55 | PKR 0.41/mL | 283% above median |
| Medisol 5% IV | Dextrose Anhydrous | 5 % | IV infusion | 500ml | 083354 | PKR 160.10 | PKR 0.32/mL | Near median |
| Medisol 5% IV | Dextrose Anhydrous | 5 % | IV infusion | 500ml | 084876 | PKR 160.10 | PKR 0.32/mL | Near median |
| Medisol 5% IV | Dextrose | 5 % | IV infusion | 250ml | 106339 | PKR 106.54 | PKR 0.43/mL | 21% above median |
| Medisol 5% IV | Dextrose | 5 % | IV infusion | 250ml | 106353 | PKR 106.54 | PKR 0.43/mL | 21% above median |
| Medisol AC | Sodium chloride + Potassium chloride + Acetic acid + Calcium chloride + Magnesium chloride + Dextrose | 210.69 + 5.22 + 6.31 + 43 + 3.56 + 35 g/1000 mL | Hemodialysis acid concentrate | 4000ml | 024012 | PKR 614.45 | PKR 0.15/mL | No comparator |
| Medisol CAPD2 | Peritoneal dialysis solution | NaCl 5.786 + Na lactate 3.92 + CaCl2 0.2573 + MgCl2 0.1017 + dextrose 15 (g/L) | Peritoneal dialysis solution | 2000ml | 011786 | PKR 192.27 | PKR 0.10/mL | No comparator |
| Medisol CAPD2 Peritoneal Dialysis | Sodium chloride + Dextrose + Calcium chloride + Sodium lactate + Magnesium chloride | NaCl 5.786g + CaCl2 0.2573g + Na lactate 3.92g + MgCl2 0.1017g + Dextrose 15.00g/1000 mL | Solution | 500ml | 011786 | PKR 150.64 | PKR 0.30/mL | No comparator |
| Medisol CAPD3 | Peritoneal dialysis solution | NaCl 5.786 + Na lactate 3.92 + CaCl2 0.2573 + MgCl2 0.1017 + dextrose 42.5 (g/L) | Peritoneal dialysis solution | 2000ml | 011787 | PKR 192.27 | PKR 0.10/mL | No comparator |
| Medisol CAPD3 Peritoneal Dialysis | Sodium chloride + Dextrose + Calcium chloride + Sodium lactate + Magnesium chloride | NaCl 5.786g + CaCl2 0.2573g + Na lactate 3.92g + MgCl2 0.1017g + Dextrose 42.50g/1000 mL | Solution | 500ml | 011787 | PKR 150.64 | PKR 0.30/mL | No comparator |
| Medisol CAPD4 | Peritoneal dialysis solution | NaCl 5.786 + Na lactate 3.92 + CaCl2 0.2573 + MgCl2 0.1017 + dextrose 22.7 (g/L) | Peritoneal dialysis solution | 2000ml | 011788 | PKR 192.27 | PKR 0.10/mL | No comparator |
| Medisol CAPD4 Peritoneal Dialysis | Sodium chloride + Dextrose + Calcium chloride + Sodium lactate + Magnesium chloride | NaCl 5.786g + CaCl2 0.2573g + Na lactate 3.92g + MgCl2 0.1017g + Dextrose 22.70g/1000 mL | Solution | 500ml | 011788 | PKR 150.64 | PKR 0.30/mL | No comparator |
| Medisol Dextrose | Dextrose | 5% | IV infusion | 1000ml | 008240 | PKR 169.29 | PKR 0.17/mL | Near median |
| Medisol Dextrose | Dextrose | 5 % | IV infusion | 50ml | 008240 | PKR 60.03 | PKR 1.20/mL | 240% above median |
| Medisol Dextrose | Dextrose Anhydrous | 5 % | IV infusion | 100ml | 008240 | PKR 92.01 | PKR 0.92/mL | 187% above median |
| Medisol Dextrose | Dextrose | 5 % | IV infusion | 500ml | 008240 | PKR 139.84 | PKR 0.28/mL | 34% below median |
| Medisol Dextrose | Dextrose | 10% | IV infusion | 1000ml | 008241 | PKR 211.62 | PKR 0.21/mL | Near median |
| Medisol Dextrose | Dextrose | 10 % | IV infusion | 500ml | 008241 | PKR 150.89 | PKR 0.30/mL | Near median |
| Medisol Dextrose | Dextrose | 25% | IV infusion | 1000ml | 011183 | PKR 197.27 | PKR 0.20/mL | Near median |
| Medisol Dextrose | Dextrose + Sodium chloride | NaCl 0.30g + Dextrose 3.3%/100 mL | IV infusion | 500ml | 024300 | PKR 88.59 | PKR 0.18/mL | No comparator |
| Medisol Dextrose 3.3% & NaCl 0.3% | Dextrose + Sodium chloride | 3.3% + 0.3% | IV infusion | 1000ml | 024300 | PKR 105.33 | PKR 0.11/mL | Near median |
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.